US equities |
NVDA $239.05 ▲+0.06% MU $1,047.30 ▼-1.57% SPCX $171.82 ▲+0.43% MRVL $287.13 ▲+5.85% AMD $649.17 ▲+2.76% INTC $112.44 ▼-3.22% SNDK $1,661.87 ▼-2.48% AVGO $375.81 ▲+3.67%
FinancialContent

Latest News about #ATTRCM

Recent news which mentions #ATTRCM

2025 HFSA CME Symposium - Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in Patients with Heart Failure: New Opportunities to Improve Patient Outcomes
Tickers CME
Tags #cmeplanet New Jersey Meded
From PRLog
2025 HFM Symposium - Optimizing the Management of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in Patients with Heart Failure
Tickers CME
Tags Event Cme Hfm2025
From PRLog